RedChip covers Trinity Biotech after 43% revenue growth
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
RedChip has initiated coverage of Trinity Biotech after the diagnostics and diabetes management company reported 43% year-over-year revenue growth in Q1 2026, reaching Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context